New advice about managing acute otitis media aims to guide but not dictate
Antenatal corticosteroids not linked to child neurodevelopment, study finds
Study in JAMA: Antenatal corticosteroids don't impact neurodevelopment in late preterm children aged 6 years and up.
Food Insecurity and the Dangers of Infant Formula Dilution
Infants born into a digital world: Are there developmental inequities based on exposure?
Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the April 2024 issue of Contemporary Pediatrics.
Demystifying Infant Formula
First radioactive drug approved for patients 12 years and up with SSTR-positive GEP-NETs
The FDA has approved lutetium Lu 177 dotatate for pediatric patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
Ustekinumab biosimilar approved to treat moderate to severe plaque psoriasis
The biosimilar to ustekinumab is approved for patients 6 years and up, and is expected to be marketed on or after February 21, 2025.